⌘K

Home/Filings/4/0001003642-17-000018

4//SEC Filing

IMPAX LABORATORIES INC 4

Accession 0001003642-17-000018

CIK 0001003642operating

View on SEC.gov Company Profile

Filed

Mar 5, 7:00 PM ET

Accepted

Mar 6, 3:07 PM ET

Size

7.1 KB

Accession

0001003642-17-000018

Insider Transaction Report

Form 4

Period: 2017-03-02

IMPAX LABORATORIES INCIPXL

President, Generics Division

Transactions

Award
Stock Option (Right to Buy)
2017-03-02+56,232→ 56,232 total
Exercise: $9.35Exp: 2027-03-02→ Common Stock (56,232 underlying)
Award
Common Stock
2017-03-02+23,272→ 85,872 total

Footnotes (1)

[F1]The option vests in four equal installments beginning on March 2, 2018, which is the first anniversary of the grant date.

Documents

1 file

4
wf-form4_148883081576403.xmlPrimary
FORM 4

Issuer

IMPAX LABORATORIES INC

CIK 0001003642

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0001003642

Filing Metadata

Form type: 4
Filed: Mar 5, 7:00 PM ET
Accepted: Mar 6, 3:07 PM ET
Size: 7.1 KB

View on SEC.gov